Transcriptomic analysis of meningioma cells IOMM-Lee treated with brusatol

This dataset comprises molecular expression profiles of human malignant meningioma IOMM-Lee cells treated with 10 nM brusatol for 48 hours. The experiment aims to elucidate the non-cytotoxic mechanisms of this natural compound at a low dose in inhibiting tumor cell growth. The data thoroughly document differentially expressed molecules between the treatment group and the vehicle control group, enabling pathway enrichment analysis and the discovery of potential therapeutic targets, thereby informing targeted therapeutic strategies for meningioma.